Ibuprofen safely dampens inflammatory markers in 28-patient drug-resistant tuberculosis trial
The Experimental Tuberculosis Unit (UTE) at the Germans Trias i Pujol Research Institute (IGTP) has published in Nature Communications the results of a phase IIa pilot clinical trial assessing…
Read the full articleYou might also wanna read
Rapid Drug Susceptibility Testing for Tuberculosis Using Raman-Deuterium Isotope Probing
Accurate and timely drug susceptibility testing (DST) is essential for tuberculosis (TB) management, especially given the global rise of mul

República Dominicana suma dos GeneXpert equipo de alta gama para reforzar el diagnóstico de la tuberculosis
El Ministerio de Salud entregó dos equipos al Servicio Nacional de Salud, con una inversión de RD 3,377,100, para acelerar pruebas molecular
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
Conditions : Ulcerative Colitis (UC) Interventions : Drug: INT-210 Capsule; Drug: INT-210 Capsule Sponsors : Innatus Therapeutics (Shanghai)
Johns Hopkins researchers develop intranasal DNA vaccine targeting drug-resistant tuberculosis
Researchers developed an intranasal DNA fusion vaccine targeting drug-tolerant tuberculosis persisters. In preclinical models, it improved b
Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)
Conditions : HIV Interventions : Other: No Intervention: Observational Cohort Sponsors : Erasmus Medical Center; EU2Cure consortium; Radboud
Tuberculosis drug discovery gets smarter with AI at Texas A&M AgriLife
New tools help researchers move faster against a global disease The post Tuberculosis drug discovery gets smarter with AI at Texas A&M AgriL

Comments
Sign in to join the conversation.
No comments yet. Be the first.